Code Pharma reported encouraging eight-week results for its HIV drug, Gammora, highlighting its potential to target HIV at the cellular level. The findings were shared at the 2024 HIV Drug
Code Pharma has reported encouraging eight-week results for its HIV drug, Gammora, suggesting a potential to eradicate the virus at the cellular level. As published on BusinessWire, the preliminary findings
Code Pharma announced positive results from an eight-week clinical trial of Gammora, suggesting the drug’s potential to target HIV at the cellular level. Preliminary findings were shared at the 2024
As published by ‘pressat’, Code Pharma, a Netherlands-based pharmaceutical company, is preparing to showcase groundbreaking findings on GAMMORA, a drug aimed at treating HIV, at two major conferences in late